Showing results (131-140 of 1,835) with videos related to
Sort By:
Pageof 184
Onkologie|August 1, 1983
[Comparison of the therapeutic efficacity of 2 induction protocols in acute myeloid leukemia using exact quantification of bone marrow cellularity]W Hiddemann, T Büchner, M Andreeff, et al.Onkologie|December 1, 1984
[Isolated hyperthermic extremity perfusion with vindesine, dacarbazine and cisplatin in the treatment of malignant melanomas]K R Aigner, A Jungbluth, K H Link, et al.Onkologie|August 1, 1983
[Therapeutic results in advanced ovarian cancer]G Kleinmanns, W Dauer, J J Knief, et al.Onkologie|November 6, 2009
Local expression of insulin-like growth factor-I, insulin-like growth factor-I receptor, and estrogen receptor alpha in ovarian cancerYuan An, Liying Cai, Yuguang Wang, et al.Onkologie|November 6, 2009
Economic impact of alternative adjuvant chemotherapy regimens for stage III colon cancerMartin Goerner, Petra Riemer-HommelOnkologie|November 6, 2009
Management of obstructive uropathy patients with advanced prostate cancer - a systematic reviewChristoph Rollig, Achim Wockel, Lothar WeissbachOnkologie|December 18, 2009
Prostate cancer with metastasis to the omentum and massive ascites: a rare manifestation of a common diseaseFlora Zagouri, Maria Papaefthimiou, Athanasios N Chalazonitis, et al.Onkologie|December 7, 2005
EGFR tyrosine kinase inhibitors in non-small cell lung cancer: report of a 3-year compassionate use experience with gefitinib in stage IIIB/IV outpatientsMartin Reck, Ulrich GatzemeierOnkologie|October 27, 2005
Pharmacogenetics of extraordinary responses to 5-FU/cisplatin chemotherapy in advanced gastric cancer -- report of 2 casesChristine Wolschke, Eray Goekkurt, Salah-Eddin Al-Batran, et al.Onkologie|December 1, 1988
[Effectiveness and side effects of recombinant alpha-2a interferon in patients with metastatic hypernephroma]F W Hirsch, B Kraaz, G W Löhr, et al.Pageof 184